The use of dexmedetomidine as an adjuvant to benzodiazepine-based therapy to decrease the severity of delirium in alcohol withdrawal in adult intensive care unit patients: a systematic review
The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Chronic alcohol consumption is a prevalent issue. Healthcare professionals often discover their patient has an alcohol consumption issue when they are admitted to the hospital and no longer have access to alcohol. The global standard for treating alcohol withdrawal syndrome (AWS) symptoms are benzodiazepines; however this therapy is often inadequate to control symptoms of delirium in adult intensive care unit (ICU) patients due to an imbalance of inhibitory and excitatory neurotransmitters. OBJECTIVES: The objective of the systematic review is to examine the clinical effectiveness of dexmedetomidine as an adjuvant to benzodiazepine-based therapy versus benzodiazepine-based therapy alone in decreasing the severity of delirium associated with AWS in adult ICU patients. INCLUSION CRITERIA: This review considered studies that included adult ICU patients over the age of 18 who were experiencing delirium associated with alcohol withdrawal. Patients admitted to the ICU with the diagnosis of AWS were included in the study.This review considered studies that evaluated dexmedetomidine as an adjuvant therapy to benzodiazepine-based therapy, compared to the use of benzodiazepine-based therapy alone in ICU patients experiencing alcohol withdrawal delirium.This review considered randomized controlled trials, non-randomized controlled trials, quasi-experimental, before and after studies, prospective and retrospective cohort studies, case control studies, analytical cross sectional studies, case series, individual case reports and descriptive cross sectional studies for inclusion.The systematic review evaluated dexmedetomidine as an adjuvant to benzodiazepine-based therapy to decrease delirium severity in alcohol withdrawal in ICU patients. The general outcome of delirium severity was measured using the Clinical Institute Withdrawal Assessment Score - Revised (CIWA), the Ramsey scale, the Richmond Agitation Sedation Score (RASS) and the Confusion Assessment Method for the ICU (CAM-ICU). SEARCH STRATEGY: The search strategy aimed to find both published and unpublished studies. A three-step search strategy was utilized in this review and included English language studies published after 1997. A search of Ovid/MEDLINE, EMBASE, Cochrane, Joanna Briggs Institute and nine other databases was conducted. METHODOLOGICAL QUALITY: Two independent reviewers using the Joanna Briggs Institute's standardized appraisal tool critically appraised the studies. A third independent reviewer was available to appraise studies if the two original reviewers disagreed in their assessments. There were no disagreements in findings between the two independent reviewers. DATA COLLECTION: Data was extracted using the standardized Joanna Briggs Institute's data extraction instruments. DATA SYNTHESIS: Statistical pooling was done using meta-analysis and findings are presented using a forest plot and narrative form. RESULTS: Four studies were included in the review, three retrospective case series and one prospective case series with a total sample size of 55 patients. Three studies used the CIWA score as the outcome measure and one study used the RASS score as the outcome measure. A meta-analysis of the three studies using the CIWA demonstrated that adjuvant use of dexmedetomidine with benzodiazepine-based therapy decreased CIWA scores (Weighted Mean Difference [WMD] -5.2, 95% Confidence Interval [CI] -6.24 to -4.16, p <0.0001). The final study using RASS scores reported improvement with adjuvant treatment with dexmedetomidine compared to benzodiazepine-based therapy alone. CONCLUSIONS: The use of dexmedetomidine as an adjuvant to benzodiazepine-based therapy decreased delirium more effectively than benzodiazepine-based therapy alone in adult ICU patients experiencing alcohol withdrawal delirium as evidenced by a decrease in CIWA and RASS scores. IMPLICATIONS FOR PRACTICE: In adult ICU patients who are experiencing alcohol withdrawal delirium that is not controlled with benzodiazepine-based therapy alone, healthcare providers should consider dexmedetomidine as an adjuvant to standard benzodiazepine-based therapy. IMPLICATIONS FOR RESEARCH: The use of dexmedetomidine in the management of delirium associated with alcohol withdrawal in adult ICU patients should be further studied via large scale randomized controlled trials.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The analysis of four studies, comprising 55 patients, demonstrated that the addition of dexmedetomidine to benzodiazepine-based therapy significantly lowered CIWA-Ar scores, indicating a positive impact on delirium severity in AWS ICU patients [36].”
From A Narrative Review of Current and Emerging Trends in the Treatment of Alcohol Use Disorder (2024) · cites this paper as [36]
Citations
Cites
Pharmacological interventions for somatoform disorders in adults
Kleinstäuber, M., Witthöft, M., Steffanowski, A., van Marwijk, H., Hiller, W., & Lambert, M. J. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010628.pub2 · Cited by 11,335
Sessler, C. N., Gosnell, M. S., Grap, M. J., Brophy, G. M., O'Neal, P. V., Keane, K. A., Tesoro, E. P., & Elswick, R. K. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2107138 · Cited by 3,695
SULLIVAN, J. T., SYKORA, K., SCHNEIDERMAN, J., NARANJO, C. A., & SELLERS, E. M. (1989) · British Journal of Addiction · doi:10.1111/j.1360-0443.1989.tb00737.x · Cited by 1,988
Room, R., Babor, T., & Rehm, J. (2005) · The Lancet · doi:10.1016/s0140-6736(05)17870-2 · Cited by 1,625
Evidence-Based Practice in Nursing and Healthcare: A Guide to Best Practice
Melnyk, B. M., & Fineout‐Overholt, E. (2004) · Medical Entomology and Zoology · Cited by 1,134
Dexmedetomidine: A Novel Sedative-Analgesic Agent
Gertler, R., Brown, H. C., Mitchell, D. H., & Silvius, E. N. (2001) · Baylor University Medical Center Proceedings · doi:10.1080/08998280.2001.11927725 · Cited by 856
Opioid antagonists for alcohol dependence
Srisurapanont, M., & Jarusuraisin, N. (2002) · The Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001867 · Cited by 764
Mayo-Smith, M. F. (1997) · JAMA · doi:10.1001/jama.278.2.144 · Cited by 434
Daeppen, J.-B., Gache, P., Landry, U., Sekera, E., Schweizer, V., Gloor, S., & Yersin, B. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.10.1117 · Cited by 258
(2000) · Handbook of Alcoholism · doi:10.1201/9781420036961-14 · Cited by 232
Understanding the health impact of alcohol dependence
Cargiulo, T. (2007) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp060647 · Cited by 218
Benzodiazepines for alcohol withdrawal
Ntais, C., Pakos, E., Kyzas, P., & Ioannidis, J. P. (2005) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005063.pub2 · Cited by 206
A double-blind trial of gabapentin versus lorazepam in the treatment of alcohol withdrawal
Myrick, H., Malcolm, R., Randall, P. K., Boyle, E., Anton, R. F., Becker, H. C., & Randall, C. L. (2009) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2009.00986.x · Cited by 201
Alcohol Withdrawal in the Surgical Patient: Prevention and Treatment
Spies, C. D., & Rommelspacher, H. (1999) · Anesthesia & Analgesia · doi:10.1097/00000539-199904000-00050 · Cited by 180
Benzodiazepines for alcohol withdrawal
Ntais, C., Kyzas, P., Pakos, E., & Ioannidis, J. (2005) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005063 · Cited by 165
Meta-analysis of benzodiazepine use in the treatment of acute alcohol withdrawal.
Holbrook, A. M., Crowther, R., Lotter, A., Cheng, C., & King, D. (1999) · Europe PMC (PubMed Central) · Cited by 153
Divalproex Sodium in Alcohol Withdrawal: A Randomized Double-Blind Placebo-Controlled Clinical Trial
Reoux, J. P., Saxon, A. J., Malte, C. A., Baer, J. S., & Sloan, K. L. (2001) · Alcoholism: Clinical and Experimental Research · doi:10.1097/00000374-200109000-00012 · Cited by 112
Treatment of alcohol withdrawal.
Myrick, H., & Anton, R. F. (1998) · PubMed Central · Cited by 109
Role of α 2 -Agonists in the Treatment of Acute Alcohol Withdrawal
Muzyk, A. J., Fowler, J. A., Norwood, D. K., & Chilipko, A. (2011) · Annals of Pharmacotherapy · doi:10.1345/aph.1p575 · Cited by 107
Baclofen for alcohol withdrawal
Liu, J., & Wang, L.-N. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008502.pub5 · Cited by 102
Dexmedetomidine as adjunct treatment for severe alcohol withdrawal in the ICU
Rayner, S. G., Weinert, C. R., Peng, H., Jepsen, S., Broccard, A. F., & Institution, S. (2012) · Annals of Intensive Care · doi:10.1186/2110-5820-2-12 · Cited by 101
Dexmedetomidine in the Treatment of Withdrawal Syndromes in Cardiothoracic Surgery Patients
Baddigam, K., Russo, P. A., Russo, J., & Tobias, J. D. (2005) · Journal of Intensive Care Medicine · doi:10.1177/0885066604273481 · Cited by 91
THE DRUG TREATMENT OF ALCOHOL WITHDRAWAL SYMPTOMS: A SYSTEMATIC REVIEW
WILLIAMS, D., & McBride, A. J. (1998) · Alcohol and Alcoholism · doi:10.1093/oxfordjournals.alcalc.a008365 · Cited by 84
Dexmedetomidine Infusion as Adjunctive Therapy to Benzodiazepines for Acute Alcohol Withdrawal
Darrouj, J., Puri, N., Prince, E., Lomonaco, A., Spevetz, A., & Gerber, D. R. (2008) · Annals of Pharmacotherapy · doi:10.1345/aph.1k678 · Cited by 69
Dexmedetomidine as an adjuvant in the treatment of alcohol withdrawal delirium: a case report
Rovasalo, A., Tohmo, H., Aantaa, R., Kettunen, E., & Palojoki, R. (2006) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2006.03.002 · Cited by 65
Anticonvulsants for alcohol withdrawal
Polycarpou, A., Papanikolau, P., Ioannidis, J. P. A., & Contopoulos‐Ioannidis, D. G. (2005) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005064.pub2 · Cited by 55
DeMuro, J. P., Botros, D. B. R., Wirkowski, E., & Hanna, A. F. (2012) · Journal of Anesthesia · doi:10.1007/s00540-012-1381-y · Cited by 53
Di Nicola, M., Martinotti, G., Tedeschi, D., Frustaci, A., Mazza, M., Sarchiapone, M., Pozzi, G., Bria, P., & Janiri, L. (2010) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/hup.1098 · Cited by 52
Tolonen, J., Rossinen, J., Alho, H., & Harjola, V.-P. (2013) · European Journal of Emergency Medicine · doi:10.1097/mej.0b013e32835c53b3 · Cited by 45
Treatment of alcohol withdrawal: tiapride and carbamazepine versus clomethiazole.
Franz, M., Dlabal, H., Kunz, S., Ulferts, J., Gruppe, H., & Gallhofer, B. (2001) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s004060170039 · Cited by 42
Weide, L. A. V., Foster, C. J., MacLaren, R., Kiser, T. H., Fish, D. N., & Mueller, S. W. (2014) · Journal of Intensive Care Medicine · doi:10.1177/0885066614554908 · Cited by 42
Psychotropic analgesic nitrous oxide for alcoholic withdrawal states
Gillman, M. A., LICHTIGFELD, F. J., & Young, T. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005190.pub2 · Cited by 31
The Anesthetic Implications of Alcoholism
Fox, C. J., Liu, H., & Kaye, A. D. (2011) · International Anesthesiology Clinics · doi:10.1097/aia.0b013e3181ff4dc0 · Cited by 11
Lemon, S. J., Winstead, P. S., & Weant, K. A. (2010) · Advanced Emergency Nursing Journal · doi:10.1097/tme.0b013e3181cae050 · Cited by 8
Management of Substance Abuse in the Hospital Setting
Gist, R. S., Sullivan, M. J., & Serianni, R. P. (2011) · International Anesthesiology Clinics · doi:10.1097/aia.0b013e3181ff4cc0 · Cited by 6
Brink, H., Peitz, G. J., Klepser, D. G., & Olsen, K. M. (2012) · Critical Care Medicine · doi:10.1097/01.ccm.0000425240.90130.d3 · Cited by 1
Research works printed but not linked: 4
- Bayard, 2004, Am Fam Physician, 69, 1443
- Holbrook, 1999, Can Med Assoc J, 160, 649
- Reoux, 2001, Alcohol Clin Exp Res, 25, 1324, 10.1111/j.1530-0277.2001.tb02354.x · doi:10.1111/j.1530-0277.2001.tb02354.x · Paper page
- Myrick, 1998, Alcohol Health Res World, 22, 38
Cited by
Strayer, R. J., Friedman, B. W., Haroz, R., Ketcham, E. M., Klein, L. R., LaPietra, A. M., Motov, S. M., Repanshek, Z. D., Taylor, S., Weiner, S. G., et al. (2023) · Journal of Emergency Medicine · doi:10.1016/j.jemermed.2023.01.010 · Cited by 53
Remy, K. E., Verhoef, P. A., Malone, J. R., Ruppe, M. D., Kaselitz, T. B., Lodeserto, F., Hirshberg, E. L., Slonim, A. D., & Dezfulian, C. (2020) · Pediatric Critical Care Medicine · doi:10.1097/pcc.0000000000002429 · Cited by 51
Bahji, A., Bach, P., Danilewitz, M., Crockford, D. N., el‐Guebaly, N., Devoe, D. J. A., & Saitz, R. (2022) · Addiction · doi:10.1111/add.15853 · Cited by 49
A Narrative Review of Current and Emerging Trends in the Treatment of Alcohol Use Disorder
Celik, M., Gold, M. S., & Fuehrlein, B. (2024) · Brain Sciences · doi:10.3390/brainsci14030294 · Cited by 25
Yavarovich, E., Bintvihok, M., McCarty, J. C., Breeze, J. L., & LaCamera, P. P. (2019) · Journal of Intensive Care · doi:10.1186/s40560-019-0405-1 · Cited by 21
Metadata
- Authors
- Woods, A. D., Giometti, R., & Weeks, S. M.
- Affiliations
- Texas Christian University (US)
- Chester County Hospital (US)
- Venue
- JBI Database of Systematic Reviews and Implementation Reports
- Published
- 2015-01
- Volume
- 13
- Issue
- 1
- Pages
- 224-252
- ISSN
- 2202-4433 (ISSN-L)
- OpenAlex
- W2133052062
- Cited by
- 23
- References
- 36
- Citations by year
- 2026: 1 · 2024: 2 · 2023: 1 · 2022: 5 · 2021: 2 · 2020: 3 · 2019: 5 · 2018: 2 · 2017: 1 · 2015: 1
- FWCI
- 0.18
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The JBI Database of Systematic Reviews and Implementation Reports (publishedVersion)
- PubMed (publishedVersion)
- Funders
- University of Pennsylvania
- Texas Christian University
- Topics
- Health Sciences › Medicine › Clinical Neurology › Alcoholism and Thiamine Deficiency
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Intensive Care Unit Cognitive Disorders
- Health Sciences › Medicine › Anesthesiology and Pain Medicine › Anesthesia and Sedative Agents
- Keywords
- dexmedetomidine, alcohol withdrawal, delirium, benzodiazepines, adjuvant therapy, intensive care unit patients, delirium severity, Richmond Agitation-Sedation Scale, CAM-ICU, delirium tremens, sedation, agitation, cost-effectiveness
- MeSH terms
- Adjuvants, Pharmaceutic, Alcohol Withdrawal Delirium, Alcoholism, Benzodiazepines, Cross-Sectional Studies, Delirium, Female, Humans, Intensive Care Units, Male, Middle Aged, Prospective Studies, Retrospective Studies, Severity of Illness Index, Meta-Analysis as Topic, Case-Control Studies, Randomized Controlled Trials as Topic, Treatment Outcome, Dexmedetomidine, Adrenergic alpha-2 Receptor Agonists
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.